Dr Hernandez-Ilizaliturri on the Implications of the FDA Approval of Liso-Cel for R/R Follicular Lymphoma

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Related Keywords

Francisco Hernandez Ilizaliturri , ,Department Of Immunology ,Biomedical Sciences ,Lymphoma Research ,Lymphoma Translational Research Lab ,Jacobs School Of Medicine ,University At Buffalo ,Roswell Park Comprehensive Cancer Center ,Department Of Medicine ,Jacobs School ,